MedTrace Logo

Clinical Characteristics of Spinal Levobupivacaine: Hyperbaric Compared With Isobaric Solution

NCT01349751 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-11-07

No results posted yet for this study

Summary

The authors would like to investigate the blocking characteristics, surgical quality and side effects of intrathecal levobupivacaine whether there are any differences between the hyperbaric and the isobaric formulation for gynaecologic surgeries which need higher block level than the urological surgeries.

Conditions

  • Observation of Neuromuscular Block
  • Disease (or Disorder); Gynecological

Interventions

DRUG

isobaric levobupivacaine

0.42% either isobaric levobupivacaine 3 ml spinal injection once

DRUG

hyperbaric levobupivacaine

0.42% hyperbaric levobupivacaine 3 ml spinal injection once

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Vimolluck - Sanansilp, MD · Dept of Anesthesiology, Faculty of Medicine Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01349751 on ClinicalTrials.gov